Want to join the conversation?
$BDC said it successfully closed mandatory convertible preferred stock offering, providing for net proceeds of $501.6MM. $BDC still sees 3Q16 revenue of $593-613MM and its adjusted revenue of $595-615MM. $BDC lowered its 3Q16 EPS outlook to $0.51-0.61 from prior range of $0.66-0.76, and its adjusted EPS forecast to 1.20-1.30 from $1.35-1.45.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.